Last reviewed · How we verify

Quinvaxem in single dose vials — Competitive Intelligence Brief

Quinvaxem in single dose vials (Quinvaxem in single dose vials) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Pentavalent conjugate vaccine. Area: Immunology / Infectious Disease.

phase 3 Pentavalent conjugate vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Quinvaxem in single dose vials (Quinvaxem in single dose vials) — Crucell Holland BV. Quinvaxem is a pentavalent conjugate vaccine that provides immunization against five bacterial pathogens by stimulating antibody and cellular immune responses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Quinvaxem in single dose vials TARGET Quinvaxem in single dose vials Crucell Holland BV phase 3 Pentavalent conjugate vaccine
Quinvaxem in Uniject Quinvaxem in Uniject Crucell Holland BV phase 3 Pentavalent conjugate vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Pentavalent conjugate vaccine class)

  1. Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quinvaxem in single dose vials — Competitive Intelligence Brief. https://druglandscape.com/ci/quinvaxem-in-single-dose-vials. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: